Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies

Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies

Abstract Since the introduction of leukemia-type induction therapies for T-cell lymphoblastic lymphoma (T-LBL), improvements in the long-term outcomes of T-LBL have been reported. However, indications for and the appropriate timing of hematopoietic stem cell transplantation (HSCT) have not yet been...

Full description

Bibliographic Details
Main Authors: Mari Morita-Fujita, Yasuyuki Arai, Satoshi Yoshioka, Takayuki Ishikawa, Junya Kanda, Tadakazu Kondo, Takashi Akasaka, Yasunori Ueda, Kazunori Imada, Toshinori Moriguchi, Kazuhiro Yago, Toshiyuki Kitano, Akihito Yonezawa, Masaharu Nohgawa, Akifumi Takaori-Kondo, Kyoto Stem Cell Transplantation Group (KSCTG)
Format: Article
Language:English
Published: Nature Publishing Group 2020-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-78334-x

Internet

https://doi.org/10.1038/s41598-020-78334-x

Similar Items